Sign in

CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 6,250 shares at $8.00 ($50,000)
  3. 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
  4. 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
  5. 4 Open-market buy President and CEO bought 12,500 shares at $8.00 ($100,000)
  6. 4 Open-market buy Director bought 9,375 shares at $8.00 ($75,000)
  7. 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
  8. 4 Derivatives Options or other derivatives
  9. 4 Conversion 10% owner acquired 21,250 shares (conversion)
  10. 4 Option exercise 10% owner acquired 72,690 shares (option exercise)
  11. 4 Conversion 10% owner acquired 9,208 shares (conversion)
  12. 4 Option exercise 10% owner acquired 121,152 shares (option exercise)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 11 of 12 · 223 filings